Literature DB >> 27730271

Nicotinic cholinergic system alterations and nitrous oxide exposure in a mouse model: a hypothesis for the pathobiology of autism spectrum disorder.

Luis E F Almeida1, Li Wang1, Alfia Khaibullina1, Zenaide M N Quezado2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27730271     DOI: 10.1007/s00213-016-4457-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  12 in total

1.  Altered nocifensive behavior in animal models of autism spectrum disorder: The role of the nicotinic cholinergic system.

Authors:  Li Wang; Luis E F Almeida; Margaret Nettleton; Alfia Khaibullina; Sarah Albani; Sayuri Kamimura; Mehdi Nouraie; Zenaide M N Quezado
Journal:  Neuropharmacology       Date:  2016-09-13       Impact factor: 5.250

2.  Carbon monoxide modulates cytochrome oxidase activity and oxidative stress in the developing murine brain during isoflurane exposure.

Authors:  Ying Cheng; Marisa J Mitchell-Flack; Aili Wang; Richard J Levy
Journal:  Free Radic Biol Med       Date:  2015-05-29       Impact factor: 7.376

Review 3.  Neurochemical correlates of autistic disorder: a review of the literature.

Authors:  Kristen S L Lam; Michael G Aman; L Eugene Arnold
Journal:  Res Dev Disabil       Date:  2005-07-05

4.  The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring.

Authors:  Wei-Li Wu; Catherine E Adams; Karen E Stevens; Ke-Huan Chow; Robert Freedman; Paul H Patterson
Journal:  Brain Behav Immun       Date:  2015-02-12       Impact factor: 7.217

Review 5.  The α7 nicotinic acetylcholine receptor: A mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome.

Authors:  Stephen I Deutsch; Jessica A Burket; Maria R Urbano; Andrew D Benson
Journal:  Biochem Pharmacol       Date:  2015-06-11       Impact factor: 5.858

6.  15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain.

Authors:  Dag H Yasui; Haley A Scoles; Shin-Ichi Horike; Makiko Meguro-Horike; Keith W Dunaway; Diane I Schroeder; Janine M Lasalle
Journal:  Hum Mol Genet       Date:  2011-08-12       Impact factor: 6.150

Review 7.  The human clinical phenotypes of altered CHRNA7 copy number.

Authors:  Madelyn A Gillentine; Christian P Schaaf
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

Review 8.  Does environmental exposure to the greenhouse gas, N2O, contribute to etiological factors in neurodevelopmental disorders? A mini-review of the evidence.

Authors:  Keith Fluegge
Journal:  Environ Toxicol Pharmacol       Date:  2016-08-18       Impact factor: 4.860

9.  Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation.

Authors:  Randal G Ross; Sharon K Hunter; M Camille Hoffman; Lizbeth McCarthy; Betsey M Chambers; Amanda J Law; Sherry Leonard; Gary O Zerbe; Robert Freedman
Journal:  Am J Psychiatry       Date:  2015-12-07       Impact factor: 18.112

Review 10.  Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders.

Authors:  Hans O Kalkman; Dominik Feuerbach
Journal:  Cell Mol Life Sci       Date:  2016-03-15       Impact factor: 9.261

View more
  2 in total

Review 1.  Molecular Mechanisms of Aberrant Neuroplasticity in Autism Spectrum Disorders (Review).

Authors:  A A Anashkina; E I Erlykina
Journal:  Sovrem Tekhnologii Med       Date:  2021-02-28

2.  Zinc and Copper Brain Levels and Expression of Neurotransmitter Receptors in Two Rat ASD Models.

Authors:  Elzbieta Zieminska; Anna Ruszczynska; Justyna Augustyniak; Beata Toczylowska; Jerzy W Lazarewicz
Journal:  Front Mol Neurosci       Date:  2021-06-29       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.